Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00466687
Status:
COMPLETED
Last Update Posted:
2013-07-22
First Post:
2007-04-25
Brief Title:
Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Vanderbilt-Ingram Cancer Center